Received Jan 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | z010457 | IM / LA |
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Reported possible infections on 1/8, 3 days after administration and being treated as a SSTI